NasdaqGM:RYTMBiotechs
Does Rhythm Pharmaceuticals (RYTM) Share Price Reflect Its Obesity Treatment Potential Today
If you are wondering whether Rhythm Pharmaceuticals' current share price lines up with its underlying value, this breakdown will help you make sense of where it stands today.
The stock recently closed at US$94.94, with returns of a 1.5% decline over 7 days, a 7.4% decline over 30 days, a 9.6% decline year to date, 81.2% over 1 year, 333.1% over 3 years and 280.4% over 5 years.
Recent news coverage has focused on Rhythm Pharmaceuticals' position in obesity and rare disease treatments, which...